Cargando…

The influence of sodium on pathophysiology of multiple sclerosis

Multiple sclerosis (MS) is a chronic, inflammatory, autoimmune disease of the central nervous system, and is an important cause of disability in young adults. In genetically susceptible individuals, several environmental factors may play a partial role in the pathogenesis of MS. Some studies suggest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zostawa, Jacek, Adamczyk, Jowita, Sowa, Paweł, Adamczyk-Sowa, Monika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331099/ https://www.ncbi.nlm.nih.gov/pubmed/28078565 http://dx.doi.org/10.1007/s10072-016-2802-8

Ejemplares similares

Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients
por: Adamczyk-Sowa, Monika, et al.
Publicado: (2016)

New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis
por: Adamczyk, Bożena, et al.
Publicado: (2016)

Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis Pathophysiology?
por: Adamczyk-Sowa, Monika, et al.
Publicado: (2017)

Role of Microglial Cells in the Pathophysiology of MS: Synergistic or Antagonistic?
por: Mado, Hubert, et al.
Publicado: (2023)

Multiple sclerosis patients and COVID-19
por: Mado, Hubert, et al.
Publicado: (2021)

Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches
por: Niedziela, Natalia, et al.
Publicado: (2016)

Melatonin Acts as Antioxidant and Improves Sleep in MS Patients
por: Adamczyk-Sowa, Monika, et al.
Publicado: (2014)

The Evaluation of Oxidative Stress Parameters in Serum Patients with Relapsing-Remitting Multiple Sclerosis Treated with II-Line Immunomodulatory Therapy
por: Adamczyk, Bożena, et al.
Publicado: (2017)

SARS-CoV-2/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy
por: Adamczyk-Sowa, Monika, et al.
Publicado: (2021)

Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment
por: Adamczyk-Sowa, Monika, et al.
Publicado: (2017)

Prospective Assessment of Risk Factors Influencing Facial Nerve Paresis in Patients after Surgery for Parotid Gland Tumors
por: Głuszkiewicz, Ewa, et al.
Publicado: (2022)

Anti-severe acute respiratory syndrome coronavirus-2 antibody responses following Pfizer-BioNTech vaccination in a patient with multiple sclerosis treated with ocrelizumab: a case report
por: Mado, Hubert, et al.
Publicado: (2021)

The course of COVID-19 infection in patients with multiple sclerosis–The experience of one center based on the population of Upper Silesia
por: Nowak-Kiczmer, Maria, et al.
Publicado: (2021)

The Rate of Hospitalization of Pregnant Women with Multiple Sclerosis in Poland
por: Walkiewicz, Dorota, et al.
Publicado: (2022)

Course of therapy in patients with active relapsing-remitting multiple sclerosis despite first-line treatment
por: Bartosik-Psujek, Halina, et al.
Publicado: (2023)

Calcium–phosphate metabolism in patients with multiple sclerosis
por: Kubicka-Baczyk, K., et al.
Publicado: (2015)

Prospective Assessment of Intraoperative Facial Nerve Monitoring in Patients Undergoing Partial Parotidectomy
por: Zieliński, Maciej, et al.
Publicado: (2022)

Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D(3)
por: Niedziela, Natalia, et al.
Publicado: (2018)

Month of birth and level of insolation as risk factors for multiple sclerosis in Poland
por: Dobrakowski, Paweł, et al.
Publicado: (2017)

Comment on the paper Negative anti-SARS-CoV-2 S antibody response following Pfizer SARS-CoV-2 vaccination in a patient on ocrelizumab: the likely explanation for this phenomenon based on our observations
por: Mado, Hubert, et al.
Publicado: (2021)

Klotho protein in neurodegenerative disorders
por: Torbus-Paluszczak, Magdalena, et al.
Publicado: (2018)

The Most Common Lesions Detected by Neuroimaging as Causes of Epilepsy
por: Adamczyk, Bożena, et al.
Publicado: (2021)

Oxidative Stress Markers Patients with Parotid Gland Tumors: A Pilot Study
por: Sowa, Pawel, et al.
Publicado: (2018)

Toxins Utilize the Endoplasmic Reticulum-Associated Protein Degradation Pathway in Their Intoxication Process
por: Nowakowska-Gołacka, Jowita, et al.
Publicado: (2019)

Relationship between stroke severity, extensity of leukoaraiosis, and brain atrophy in patients with ischaemic stroke
por: Marek, Marta, et al.
Publicado: (2019)

Management of multiple sclerosis patients in central European countries: current needs and potential solutions
por: Berger, Thomas, et al.
Publicado: (2018)

What is the role of adipokines in myasthenia gravis?
por: Rozmilowska, Izabela, et al.
Publicado: (2018)

Intracellular Transport and Cytotoxicity of the Protein Toxin Ricin
por: Sowa-Rogozińska, Natalia, et al.
Publicado: (2019)

Bilateral paralysis of peroneal nerve after COVID-19 disease: a case report
por: Morawiec, Natalia, et al.
Publicado: (2022)

Modified Rio Score with Platform Therapy Predicts Treatment Success with Fingolimod and Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients
por: Jamroz-Wiśniewska, Anna, et al.
Publicado: (2021)

Factors influencing daily treatment choices in multiple sclerosis: practice guidelines, biomarkers and burden of disease
por: Berger, Thomas, et al.
Publicado: (2020)

Impact of B cells to the pathophysiology of multiple sclerosis
por: Arneth, Borros M.
Publicado: (2019)

Erythrocytes in multiple sclerosis – forgotten contributors to the pathophysiology?
por: Groen, Kira, et al.
Publicado: (2016)

EDEM1 Regulates Amyloid Precursor Protein (APP) Metabolism and Amyloid-β Production
por: Nowakowska-Gołacka, Jowita, et al.
Publicado: (2021)

The Big Five Personality Traits and Positive Orientation in Polish Adults with Multiple Sclerosis: The Role of Meaning in Life
por: Szcześniak, Małgorzata, et al.
Publicado: (2022)

Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis
por: Dolcetti, Ettore, et al.
Publicado: (2020)

The Comparison of the Selected Parameters of Brain Injury and Interleukins in the CSF in Patients Diagnosed De Novo with RRMS Compared to the Control Group
por: Adamczyk, Bożena, et al.
Publicado: (2023)

Symptoms after COVID-19 Infection in Individuals with Multiple Sclerosis in Poland
por: Czarnowska, Agata, et al.
Publicado: (2021)

Significance of the Diagnosis of Executive Functions in Patients with Relapsing-Remitting Multiple Sclerosis
por: Borkowska, Aneta R., et al.
Publicado: (2021)

Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications
por: Dudani, Sharmila J, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_i333ah8kkcs4iqlaev32g70sq7